疤痕剖宫产妊娠一例报告

A. Dua, Arzoo Amin, Z. Amin
{"title":"疤痕剖宫产妊娠一例报告","authors":"A. Dua, Arzoo Amin, Z. Amin","doi":"10.31487/j.crogr.2019.01.04","DOIUrl":null,"url":null,"abstract":"Introduction: The overall incidence of Cesarean scar pregnancy is increasing due to Cesarean rates. This\nlife-threatening condition has been historically managed in various ways as no single modality is reliable\nenough. We report this case of live CSP managed initially with Fetocide followed by Methotrexate but\nrequiring Surgical management later on.\nPresentation: A 32 years old para 5 with four previous Cesarean sections was diagnosed with live CSP.\nHCG level was 76,619. The initial management was fetocide with KCL followed by Methotrexate. The\ntreatment was considered successful in view of appropriate reduction in serum HCG levels. The woman\nrequired surgical management 10 weeks after the initial management, but the blood loss was minimal.\nDiscussion: A CSP may be asymptomatic or present with non-specific symptoms. The rate of initial\nmisdiagnosis is as high as 76%. TVUSS enables correct CSP diagnosis and implementation of minimally\ninvasive effective treatment. HCG levels can affect the overall outcome, but medical management can be\nconsidered even with high HCG levels.\nConclusion: CSP is a life-threatening condition, therefore timely diagnosis and appropriate management is\ncrucial. Medical management can be considered in most cases even with high HCG, but management has\nto be tailored according to the patient. Close follow up of patient after Medical treatment is important as\nthey may require further intervention.","PeriodicalId":416165,"journal":{"name":"Case Reports in Obstetrics Gynecology and Reproductive","volume":"18 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Live Cesarean Scar Pregnancy: A Case Report\",\"authors\":\"A. Dua, Arzoo Amin, Z. Amin\",\"doi\":\"10.31487/j.crogr.2019.01.04\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: The overall incidence of Cesarean scar pregnancy is increasing due to Cesarean rates. This\\nlife-threatening condition has been historically managed in various ways as no single modality is reliable\\nenough. We report this case of live CSP managed initially with Fetocide followed by Methotrexate but\\nrequiring Surgical management later on.\\nPresentation: A 32 years old para 5 with four previous Cesarean sections was diagnosed with live CSP.\\nHCG level was 76,619. The initial management was fetocide with KCL followed by Methotrexate. The\\ntreatment was considered successful in view of appropriate reduction in serum HCG levels. The woman\\nrequired surgical management 10 weeks after the initial management, but the blood loss was minimal.\\nDiscussion: A CSP may be asymptomatic or present with non-specific symptoms. The rate of initial\\nmisdiagnosis is as high as 76%. TVUSS enables correct CSP diagnosis and implementation of minimally\\ninvasive effective treatment. HCG levels can affect the overall outcome, but medical management can be\\nconsidered even with high HCG levels.\\nConclusion: CSP is a life-threatening condition, therefore timely diagnosis and appropriate management is\\ncrucial. Medical management can be considered in most cases even with high HCG, but management has\\nto be tailored according to the patient. Close follow up of patient after Medical treatment is important as\\nthey may require further intervention.\",\"PeriodicalId\":416165,\"journal\":{\"name\":\"Case Reports in Obstetrics Gynecology and Reproductive\",\"volume\":\"18 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Obstetrics Gynecology and Reproductive\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31487/j.crogr.2019.01.04\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Obstetrics Gynecology and Reproductive","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31487/j.crogr.2019.01.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

剖宫产疤痕妊娠的总体发生率随着剖宫产率的增加而增加。这种危及生命的疾病历来有多种治疗方法,因为没有一种方法足够可靠。我们报告这例活的CSP,最初用Fetocide治疗,随后用甲氨蝶呤治疗,但后来需要手术治疗。报告:一个32岁的第5段,有4次剖宫产被诊断为活CSP。HCG为76,619。最初的治疗方法是用KCL杀死胎儿,然后用甲氨蝶呤。考虑到血清HCG水平的适当降低,治疗被认为是成功的。这名妇女在初次治疗10周后需要手术治疗,但失血很少。讨论:CSP可能无症状或有非特异性症状。最初的误诊率高达76%。TVUSS能够正确诊断CSP并实施微创有效治疗。HCG水平可以影响整体结果,但即使HCG水平高,也可以考虑医疗管理。结论:CSP是一种危及生命的疾病,及时诊断和适当治疗至关重要。在大多数情况下,即使HCG高,也可以考虑医疗管理,但管理必须根据患者量身定制。患者在接受药物治疗后的密切随访很重要,因为他们可能需要进一步的干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Live Cesarean Scar Pregnancy: A Case Report
Introduction: The overall incidence of Cesarean scar pregnancy is increasing due to Cesarean rates. This life-threatening condition has been historically managed in various ways as no single modality is reliable enough. We report this case of live CSP managed initially with Fetocide followed by Methotrexate but requiring Surgical management later on. Presentation: A 32 years old para 5 with four previous Cesarean sections was diagnosed with live CSP. HCG level was 76,619. The initial management was fetocide with KCL followed by Methotrexate. The treatment was considered successful in view of appropriate reduction in serum HCG levels. The woman required surgical management 10 weeks after the initial management, but the blood loss was minimal. Discussion: A CSP may be asymptomatic or present with non-specific symptoms. The rate of initial misdiagnosis is as high as 76%. TVUSS enables correct CSP diagnosis and implementation of minimally invasive effective treatment. HCG levels can affect the overall outcome, but medical management can be considered even with high HCG levels. Conclusion: CSP is a life-threatening condition, therefore timely diagnosis and appropriate management is crucial. Medical management can be considered in most cases even with high HCG, but management has to be tailored according to the patient. Close follow up of patient after Medical treatment is important as they may require further intervention.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信